Spectral Medical Provides January Tigris Trial Update -January 30, 2024 at 0820 am EST - Marketscreener.com
| SD4 Stock | EUR 0.37 0.01 2.78% |
Roughly 55% of SPECTRAL MEDICAL's stockholders are presently thinking to get in. The analysis of current outlook of investing in SPECTRAL MEDICAL suggests that some traders are interested regarding SPECTRAL MEDICAL's prospects. The current market sentiment, together with SPECTRAL MEDICAL's historical and current headlines, can help investors time the market. In addition, many technical investors use SPECTRAL MEDICAL stock news signals to limit their universe of possible portfolio assets.
SPECTRAL MEDICAL stock news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of SPECTRAL daily returns and investor perception about the current price of SPECTRAL MEDICAL as well as its diversification or hedging effects on your existing portfolios.
SPECTRAL |
Spectral Medical Provides January Tigris Trial Update -January 30, 2024 at 0820 am EST Marketscreener.com
Read at news.google.com
 |
SPECTRAL MEDICAL Fundamental Analysis
We analyze SPECTRAL MEDICAL's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of SPECTRAL MEDICAL using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of SPECTRAL MEDICAL based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Beta
Beta Comparative Analysis
SPECTRAL MEDICAL is currently under evaluation in beta category among its peers. Beta is one of the most important measures of equity market volatility. Beta can be thought of as asset elasticity or sensitivity to market. In other words, it is a number that shows the relationship of an equity instrument to the financial market in which this instrument is traded. For example, if Beta of equity is 2, it is expected to significantly outperform market when the market is going up and significantly underperform when the market is going down. Similarly, Beta of 1 indicates that an asset and market will generate similar returns over time.
SPECTRAL MEDICAL Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with SPECTRAL MEDICAL stock to make a market-neutral strategy. Peer analysis of SPECTRAL MEDICAL could also be used in its relative valuation, which is a method of valuing SPECTRAL MEDICAL by comparing valuation metrics with similar companies.
Peers
SPECTRAL MEDICAL Related Equities
| SHL | Siemens Healthineers | 1.91 | ||||
| DAP | Danaher | 1.49 | ||||
| TN8 | Thermo Fisher | 0.43 | ||||
| AG8 | Agilent Technologies | 1.91 |
Complementary Tools for SPECTRAL Stock analysis
When running SPECTRAL MEDICAL's price analysis, check to measure SPECTRAL MEDICAL's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy SPECTRAL MEDICAL is operating at the current time. Most of SPECTRAL MEDICAL's value examination focuses on studying past and present price action to predict the probability of SPECTRAL MEDICAL's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move SPECTRAL MEDICAL's price. Additionally, you may evaluate how the addition of SPECTRAL MEDICAL to your portfolios can decrease your overall portfolio volatility.
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |